GorelickPB: Life after ESPRIT: Which first-line antiplatelet treatment should we use?Int J Stroke2007; 2: 40–2.
4.
KennedyJBuchanAM: Moving forward with intra-arterial and intravenous stroke treatment. Int J Stroke2007; 2: 45–6.
5.
KöhrmannMSchellingerPD: Stroke-MRI: Extending the time-window: Recent trials and clinical practice. Int J Stroke2007; 2: 53–4.
6.
JungKHSongECLeeST. Circulating endothelial progenitor cells as a potential marker of endothelial dysfunction or repair in stroke. Stroke2007; 38: 457.
7.
ElkinsJSLongstrethWTManolioTANewmanABBhadeliaRAJohnstonCS: MRI-defined brain infarct is associated with greater cognitive decline in hypertensives despite similar lesion size and location. Stroke2007; 38: 484.
LiebeskindDSCotsonisGASaverJS. WASID investigators. Collateral flow greatly impacts the risk of stroke with intracranial atherosclerosis. Stroke2007; 38: 477.
10.
LiebeskindDSSaverJL: MERCI/Multi MERCI investigators. Collateral failure? Unsuccessful recanalization in MERCI and Multi MERCI. Stroke2007; 38: 478.
11.
HowardVJLacklandDTLitchmanJH. Factors associated with care-seeking behavior in response to stroke symptoms: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke2007; 38: 528.
12.
TealPAShermanDGSelchenDH. On behalf of the RREACT investigators. Arundic acid (ONO-2506, MK-0724) in acute ischemic stroke: Results of RREACT study. Stroke2007; 38: 472.
13.
ChristofordisGAMohammadYYangMCaragineLSlivkaA: Factors associated with a “Lazarus Phenomenon” 24 hours following intraarterial thrombolytic treatment in acute ischemic stroke. Stroke2007; 38: 507.
14.
VahediKHofmeijerJJuettlerE. DECIMAL, DESTINY, and HAMLET investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials. Lancet Neurol2007; 6: 215–22.
15.
ShermanDGAlbersGWBladinC. Venous thromboembolism prophylaxis with enoxeparin versus unfractioned heparin and timing of initiation in acute ischemic stroke patients. Stroke2007; 38: LB1.